The treatment landscape for multiple myeloma, the second most common blood cancer, is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent.
May 24 2024University of Miami Miller School of Medicine The , the second most common blood cancer , is shifting rapidly, with newly diagnosed patients increasingly being treated with a four-part drug combination that includes a new immunotherapy agent.
"These are great improvements for patients, and they deliver deep responses," said Landgren, chief of the Myeloma Division and director of the Myeloma Research Institute at Sylvester Comprehensive Cancer Center, part of the University of Miami Miller School of Medicine. The studies are testing the hypothesis that the addition of an antibody will provide deeper responses in more patients, and a longer duration of the clinical benefit of progression-free and overall survival. The implications are that patients can live longer without having the disease come back, and live longer overall.It could have additional implications beyond the clinical outcomes, and impact how we use other therapies.
Related StoriesTell us more about potentially reducing the need for bone marrow and stem cell transplantation. Key factors are access to newer drugs as well as treatment traditions. For instance, not all drugs are available in all countries outside the U.S., and within the U.S. some physicians are early adopters while others are slower to update treatment strategies. Myeloma experts who treat large numbers of patients may feel more comfortable implementing newer strategies sooner, compared to more general hematology/oncology physicians who only treat a handful of new multiple myeloma patients every year.
Myeloma Antibodies Antibody Blood Blood Cancer Cancer Cell Drugs Hematology Immunotherapy Medicine Monoclonal Antibody Oncology Ph Protein Research Transplant Tumor
United Kingdom Latest News, United Kingdom Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
Josh Egesi on his designs and evolving culture: 'Design is a form of cultural documentation'Mazzi Odu is a Ugandan-British writer, editor and cultural consultant based in Lagos, Nigeria. Her work focuses on jewellery, design, fashion and art.
Read more »
Negotiating the evolving data storage landscapeHow Pure Storage can smooth the journey of keeping up with constant change
Read more »
Novel bispecific antibodies show promise against evolving SARS-CoV-2 variantsResearchers developed bispecific antibodies targeting both the N-terminal and receptor binding domains of SARS-CoV-2, demonstrating significant neutralization across various Omicron variants, suggesting potential for new COVID-19 treatments.
Read more »
Long COVID definitions, care models are evolvingDefinitions of long COVID and care models are evolving, but considerable variability is seen in these models, according to a review published online May 21 in the Annals of Internal Medicine.
Read more »
Law firms start generative AI rollout, with safeguardsLawyers working to keep up with the evolving technology remain wary of risks
Read more »
Visualize your critical cyber risksHow to empower CISOs and mitigate cyber security risks in a rapidly evolving threat landscape
Read more »